drugset / Trial / NCT01495195
Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
Phase 2
Completed
12 enrolled
Midwest Biomedical Research Foundation
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
No medications are currently available for treatment of psychostimulant addiction, a compulsive preoccupation with use of cocaine and related compounds. Donepezil is a medication that is currently prescribed for Alzheimer's disease, and selegiline is a medication used for treatment of Parkinson's Disease. Both of these medications can decrease the amount of cocaine injections that laboratory animals choose to inject by vein. This project will determine if combined treatment with donepezil and selegiline can also decrease cocaine-motivated behavior for human subjects in a laboratory setting.
Timeline
- Start
- 2012-02
- Primary completion
- 2013-05
- Completion
- 2013-05
Publications
- Background Grasing K, Mathur D, Newton TF, DeSouza C. Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. Drug Alcohol Depend. 2010 Feb 1;107(1):69-75. doi: 10.1016/j.drugalcdep.2009.09.010.
- Background Grasing K, Yang Y, He S. Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine. Behav Pharmacol. 2011 Feb;22(1):58-70. doi: 10.1097/FBP.0b013e3283428cd8.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 10 mg | Oral |
| Subject | Donepezil | Small molecule | 22.5 mg | Oral |
| Subject | Selegiline | Unknown | 6 mg | Other |